Compare Phenomix vs Regentis Biomaterials
Customers evaluate the quality of Phenomix's products using the following success metrics.
Overview
Phenomix is 23 yrs old and is based in United States.
Phenomix a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets.
Regentis Biomaterials is 20 yrs old and is based in Israel.
Regentis Biomaterials develops and commercializes hydrogels for tissue regeneration. Its Gelrin hydrogel platform is a matrix of polyethylene glycol diacrylate (PEG-DA) and denatured fibrinogen, combining the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications. The company's flagship product, GelrinC, is used for the treatment of articular cartilage lesions. The company was founded in 2023 and is based in Or Akiva, Israel.
Demo Video
Leadership
Keats Nelms (Founder)
Dror Seliktar (Founder)
Investors
Presidio Partners, Sofinnova Ventures
OceanTech Acquisitions I , Horizon 2020
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Phenomix has not claimed their profile.
Work for Phenomix? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Phenomix?
Claim your profile now.
Information not available because Regentis Biomaterials has not claimed their profile.
Work for Regentis Biomaterials? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Regentis Biomaterials?
Claim your profile now.